Pentazocine And Naloxone Tablet
Product Images NDC 0591-0395

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pentazocine And Naloxone (NDC 0591-0395). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

Chemical structure of Pentazocine Hydrochloride, showing its molecular arrangement including aromatic and ring structures with a hydrochloride group.*

FDA Label Image

Structural Formula (Image 2)

Chemical structure of Pentazocine Hydrochloride shown as a molecular diagram with atoms and bonds, including a hydrochloride (HCl) component.*

FDA Label Image

Ndc 0591-0395-01 Civ Pentazocine And Naloxone Tablets, Usp 50 mg*/0.5mg* 100 Tablets Rx Only (Image 3)

Packaging label for Pentazocine Hydrochloride and Naloxone Hydrochloride Tablets, USP, containing 50 mg of Pentazocine and 0.5 mg of Naloxone per tablet. The label displays the product is supplied by Actavis Pharma, Inc. and includes a NDC number 0591-0395. The label includes dosage information, a warning to dispense the Medication Guide, quantity of 100 tablets, and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.